These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3762656)

  • 1. Medium for susceptibility testing and yeast phase conversion of Blastomyces dermatitidis.
    Kurup VP; Resnick A; Rose HD
    Mycopathologia; 1986 Jul; 95(1):25-8. PubMed ID: 3762656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cottonseed extract versus pharmamedia for the in vitro mould-yeast conversion of Blastomyces dermatitidis.
    Chaturvedi S; Randhawa HS; Chaturvedi VP; Khan ZU
    J Med Vet Mycol; 1990; 28(2):139-45. PubMed ID: 2380881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of seed-based media for the mould-yeast conversion of Blastomyces dermatitidis.
    Chaturvedi S; Randhawa HS; Chaturvedi VP; Khan ZU
    Mycopathologia; 1991 Nov; 116(2):87-96. PubMed ID: 1780002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergy of itraconazole with macrophages in killing Blastomyces dermatitidis.
    Brummer E; Bhagavathula PR; Hanson LH; Stevens DA
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2487-92. PubMed ID: 1336949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monosaccharide and chitin content of cell walls of Histoplasma capsulatum and Blastomyces dermatitidis.
    Domer JE
    J Bacteriol; 1971 Sep; 107(3):870-7. PubMed ID: 5095293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of Blastomyces dermatitidis to the yeast form at 37 degrees C and 26 degrees C.
    Kane J
    J Clin Microbiol; 1984 Sep; 20(3):594-6. PubMed ID: 6490843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAPID QUANTITATIVE METHOD FOR MEASURING THE SENSITIVITY OF BLASTOMYCES DERMATITIDIS TO FUNGISTATIC AGENTS.
    GUIDRY DJ; MAIER F
    J Bacteriol; 1963 Mar; 85(3):504-8. PubMed ID: 14042924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the conidium in dimorphism of Blastomyces dermatitidis.
    Garrison RG; Boyd KS
    Mycopathologia; 1978 Sep; 64(1):29-33. PubMed ID: 213723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological conversion of Blastomyces dermatitidis in tap-water.
    Sheiban ZB
    Bull World Health Organ; 1974; 51(4):423-7. PubMed ID: 4549493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blastomyces dermatitidis produces melanin in vitro and during infection.
    Nosanchuk JD; van Duin D; Mandal P; Aisen P; Legendre AM; Casadevall A
    FEMS Microbiol Lett; 2004 Oct; 239(1):187-93. PubMed ID: 15451118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable colonial phenotypic expression and comparison to nuclei number in Blastomyces dermatitidis.
    Clemons KV; Hurley SM; Treat-Clemons LG; Stevens DA
    J Med Vet Mycol; 1991; 29(3):165-77. PubMed ID: 1716307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of brain heart infusion-egg albumen agar, yeast extract phosphate agar and peptone glucose agar media for isolation of Blastomyces dermatitidis from sputum.
    Chaturvedi S; Randhawa HS; Chaturvedi VP; Khan ZU
    Mycopathologia; 1990 Nov; 112(2):105-12. PubMed ID: 2293031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blastomyces dermatitidis: production of the sexual stage.
    McDonough ES; Lewis AL
    Science; 1967 Apr; 156(3774):528-9. PubMed ID: 6021679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and characterization of bys1, a temperature-dependent cDNA specific to the yeast phase of the pathogenic dimorphic fungus Blastomyces dermatitidis.
    Burg EF; Smith LH
    Infect Immun; 1994 Jun; 62(6):2521-8. PubMed ID: 8188377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macroscopic and microscopic characteristics of an African Blastomyces dermatitidis strain.
    Mercantini R; Marsella R; Moretto D; Mercantini P; Balus L; Mastroianni A; Ferraro C
    Mycoses; 1995; 38(11-12):477-80. PubMed ID: 8720199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordant influence of Blastomyces dermatitidis yeast-phase-specific gene BYS1 on morphogenesis and virulence.
    Krajaejun T; Wüthrich M; Gauthier GM; Warner TF; Sullivan TD; Klein BS
    Infect Immun; 2010 Jun; 78(6):2522-8. PubMed ID: 20368350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SEROLOGICAL CHARACTERIZATION OF PATHOGENIC FUNGI BY MEANS OF FLUORESCENT ANTIBODIES. I. ANTIGENIC RELATIONSHIPS BETWEEN YEAST AND MYCELIAL FORMS OF HISTOPLASMA CAPSULATUM AND BLASTOMYCES DERMATITIDIS.
    KAUFMAN L; KAPLAN W
    J Bacteriol; 1963 May; 85(5):986-91. PubMed ID: 14044028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoidentification of Histoplasma capsulatum and Blastomyces dermatitidis with commercial exoantigen reagents. Effect of culture age.
    Body BA; Spicer A; Burgwyn CM
    Arch Pathol Lab Med; 1988 May; 112(5):519-22. PubMed ID: 3358653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective expression of the virulence factor BAD1 upon morphogenesis to the pathogenic yeast form of Blastomyces dermatitidis: evidence for transcriptional regulation by a conserved mechanism.
    Rooney PJ; Sullivan TD; Klein BS
    Mol Microbiol; 2001 Feb; 39(4):875-89. PubMed ID: 11251809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of systemic mycoses with ketoconazole: in vitro susceptibilities of clinical isolates of systemic and pathogenic fungi to ketoconazole.
    Shadomy S; White SC; Yu HP; Dismukes WE
    J Infect Dis; 1985 Dec; 152(6):1249-56. PubMed ID: 3905985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.